maneb and Pheochromocytoma

maneb has been researched along with Pheochromocytoma* in 1 studies

Other Studies

1 other study(ies) available for maneb and Pheochromocytoma

ArticleYear
Melatonin inhibits maneb-induced aggregation of alpha-synuclein in rat pheochromocytoma cells.
    Journal of pineal research, 2007, Volume: 42, Issue:2

    Melatonin, a secretory product of the pineal gland, is involved in the regulation of circadian and seasonal rhythms, in oncostasis, and in inducing osteoblast differentiation. Furthermore, melatonin is a scavenger of a number of reactive oxygen and reactive nitrogen species both in vitro and in vivo. In this study, the antioxidant nature of melatonin was shown to prevent cultured neural cells from apoptosis induced by endocrine-disrupting chemical, maneb. The neurotoxicity of the fungicide, maneb (1 microg/mL), on the PC12 cells was elicited through apoptotic cell death, concomitant with aggregation of alpha-synuclein, a feature of Parkinson's disease. Activation of caspase-3/7 was associated with this process. A fluorescence rationing technique using a mitochondrial dye revealed that maneb altered the mitochondrial membrane potential of the neural cells. However, melatonin (1 nm) largely prevented the neural cells from the neural toxicant by inhibition of both caspase-3/7 activation and disruption of the mitochondrial transmembrane potential. Furthermore, aggregation of alpha-synuclein by maneb was also inhibited by melatonin. Thus, melatonin prevents maneb-induced neurodegeneration at a nighttime physiological blood concentration, most likely by inhibiting the aggregation of alpha-synuclein as well as preventing mitochondrial dysfunction in PC 12 cells.

    Topics: Adrenal Gland Neoplasms; alpha-Synuclein; Animals; Fungicides, Industrial; Maneb; Melatonin; PC12 Cells; Pheochromocytoma; Rats

2007